Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma
Clinical trial NCT03504696 · COMPLETED
Trial details
- NCT number
- NCT03504696
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-20
- Primary completion
- 2018-02-20
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.